慢阻肺左心室充盈受损的表型特征与死亡风险
该研究基于COSYCONET队列1752例稳定期COPD患者,用经胸超声心动图区分小左心室与HFpEF特征两种左心室充盈受损模式,随访4.5年发现两者全因死亡率均高于心脏超声正常者,且小左心室为独立预测因子。
要点
- COPD患者中小左心室与HFpEF特征分别占8%和16%,全因死亡率均显著升高。
- 小左心室是全因死亡的独立预测因子,校正加重频率及肺功能指标后仍显著。
- 小左心室者E/A降低但E/e'及NT-proBNP、hs-TnI正常,可与HFpEF特征鉴别。
核心结论
- COPD中小左心室与HFpEF特征均与全因死亡率升高相关,代表两种不同的左心室充盈受损模式。
研究设计与样本
- COSYCONET队列中1752例稳定期COPD患者接受经胸超声心动图检查,随访4.5年评估全因死亡率。
主要发现
- 小左心室、HFpEF特征和心脏超声正常者的频率分别为8%、16%和45%。
- 小左心室和HFpEF特征患者全因死亡风险高于心脏超声正常者,风险比分别为2.75(95%CI 1.54-4.89)和2.16(95%CI 1.30-3.61)。
- 小左心室在校正加重频率及残气量、DlCO或FEV1等混杂因素后仍为全因死亡的独立预测因子。
- 与心脏超声正常者相比,小左心室者E/A降低,但E/e'正常且NT-proBNP和hs-TnI浓度较低,不同于HFpEF特征患者。
临床怎么用
- COPD患者行超声心动图时需关注左心室大小,小左心室提示充盈受损且死亡风险升高。
- 可通过E/A、E/e'及NT-proBNP、hs-TnI区分小左心室与HFpEF特征两种模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: In chronic obstructive pulmonary disease (COPD), impaired left ventricular (LV) filling might be associated with coexisting heart failure with preserved ejection fraction (HFpEF) or due to reduced pulmonary venous return indicated by small LV size. Objectives: We investigated the all-cause mortality associated with small LV or HFpEF and clinical features discriminating between both patterns of impaired LV filling in patients with COPD. Methods: We performed transthoracic echocardiography (TTE) in patients with stable COPD from the COSYCONET (COPD and Systemic Consequences and Comorbidities Network) cohort to define small LV as LV end-diastolic diameter below the normal range and HFpEF features according to recommendations of the European Society of Cardiology. We assessed the ratio of early to late ventricular filling velocity (E/A), ratio of early mitral inflow velocity to annular early diastolic velocity (E/e'), serum N-terminal pro-brain natriuretic peptide, high-sensitivity troponin I, airflow limitation (FEV1), lung hyperinflation (residual volume), and gas transfer capacity (DlCO) and discriminated patients with small LV from those with HFpEF features or no relevant cardiac dysfunction as per TTE (normalTTE). The primary outcome was all-cause mortality after 4.5 years. Measurements and Main Results: In 1,752 patients with COPD, the frequency of small LV, HFpEF features, and normalTTE was 8%, 16%, and 45%, respectively. Patients with small LV or HFpEF features had higher all-cause mortality rates than patients with normalTTE: hazard ratio, 2.75 (95% confidence interval, 1.54-4.89) and 2.16 (95% confidence interval, 1.30-3.61), respectively. Small LV remained an independent predictor of all-cause mortality after adjusting for confounders including exacerbation frequency and measures of residual lung volume, DlCO, or FEV1. Compared with normalTTE, patients with small LV had reduced LV filling, as indicated by lowered E/A. Yet, in contrast to patients with HFpEF features, patients with small LV had normal LV filling pressure (E/e') and lower concentrations of N-terminal pro-brain natriuretic peptide and high-sensitivity troponin I. Conclusions: In COPD, both small LV and HFpEF features are associated with increased all-cause mortality and represent two distinct patterns of impaired LV filling. Clinical trial registered with www.clinicaltrials.gov (NCT01245933).
引用
- Abdo, Watz, Alter, et al. Characterization and Mortality Risk of Impaired Left Ventricular Filling in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2025. PMID: 38984876. doi:10.1164/rccm.202310-1848OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。